Ingenia Therapeutics Inc. (KOSDAQ:950260)
23,200
+3,000 (14.85%)
At close: Nov 18, 2026
Ingenia Therapeutics Market Cap
Ingenia Therapeutics has a market cap or net worth of 1.15 trillion as of November 17, 2026. It is the 11,513th most valuable company in the world and the 280th biggest in South Korea.
Market Cap
1.15T
Enterprise Value
1.13T
Revenue
7.42B
Global Rank
Country Rank
#280 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 18, 2026, Ingenia Therapeutics's market cap has increased from 889.51B to 1.15T, an increase of 28.96%. That is a compound annual growth rate of 174.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.15T | 14.85% |
| Nov 17, 2026 | 998.78B | -0.74% |
| Nov 16, 2026 | 1.01T | 1.24% |
| Nov 13, 2026 | 993.84B | -4.74% |
| Nov 12, 2026 | 1.04T | 1.69% |
| Nov 11, 2026 | 1.03T | 0.48% |
| Nov 10, 2026 | 1.02T | 3.25% |
| Nov 9, 2026 | 988.89B | 12.80% |
| Nov 6, 2026 | 876.65B | -11.79% |
| Nov 5, 2026 | 993.84B | 2.97% |
| Nov 4, 2026 | 965.16B | -3.60% |
| Nov 3, 2026 | 1.00T | -5.37% |
| Nov 2, 2026 | 1.06T | -4.25% |
| Oct 30, 2026 | 1.11T | -4.89% |
| Oct 29, 2026 | 1.16T | -0.42% |
| Oct 28, 2026 | 1.17T | 1.51% |
| Oct 27, 2026 | 1.15T | 0.22% |
| Oct 26, 2026 | 1.15T | 7.16% |
| Oct 23, 2026 | 1.07T | 4.59% |
| Oct 22, 2026 | 1.02T | -9.01% |
| Oct 21, 2026 | 1.12T | 3.17% |
| Oct 20, 2026 | 1.09T | -1.56% |
| Oct 19, 2026 | 1.11T | -6.67% |
| Oct 16, 2026 | 1.19T | 6.19% |
| Oct 15, 2026 | 1.12T | -2.38% |
| Oct 14, 2026 | 1.14T | -0.64% |
| Oct 13, 2026 | 1.15T | -5.48% |
| Oct 12, 2026 | 1.22T | -2.76% |
| Oct 8, 2026 | 1.25T | -9.14% |
| Oct 7, 2026 | 1.38T | -4.62% |
| Oct 6, 2026 | 1.45T | 1.39% |
| Oct 2, 2026 | 1.43T | -0.35% |
| Oct 1, 2026 | 1.43T | 11.35% |
| Sep 30, 2026 | 1.29T | 2.77% |
| Sep 29, 2026 | 1.25T | 3.90% |
| Sep 28, 2026 | 1.20T | -0.20% |
| Sep 23, 2026 | 1.21T | 4.05% |
| Sep 22, 2026 | 1.16T | 9.07% |
| Sep 21, 2026 | 1.06T | 16.40% |
| Sep 18, 2026 | 913.24B | 3.01% |
| Sep 17, 2026 | 886.54B | 14.28% |
| Sep 16, 2026 | 775.79B | 3.56% |
| Sep 15, 2026 | 749.09B | 6.32% |
| Sep 14, 2026 | 704.59B | -7.77% |
| Sep 11, 2026 | 763.92B | -6.42% |
| Sep 10, 2026 | 816.33B | 3.19% |
| Sep 9, 2026 | 791.11B | -0.87% |
| Sep 8, 2026 | 798.04B | -0.55% |
| Sep 7, 2026 | 802.49B | 4.17% |
| Sep 4, 2026 | 770.35B | -1.52% |
| Sep 3, 2026 | 782.21B | -8.29% |
| Sep 2, 2026 | 852.92B | -10.58% |
| Sep 1, 2026 | 953.79B | 9.35% |
| Aug 31, 2026 | 872.20B | -2.00% |
| Aug 28, 2026 | 890.00B | 3.75% |
| Aug 27, 2026 | 857.86B | 0.06% |
| Aug 26, 2026 | 857.37B | 4.71% |
| Aug 25, 2026 | 818.80B | 9.31% |
| Aug 24, 2026 | 749.09B | -3.93% |
| Aug 21, 2026 | 779.74B | -13.97% |
| Aug 20, 2026 | 906.32B | 30.00% |
| Aug 19, 2026 | 697.17B | -21.62% |
| Aug 18, 2026 | 889.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 341.72B |
| DreamCIS | 93.85B |
| HLB bioStep | 66.50B |
| P&K Skin Research Center | 52.04B |
| Kolmar BioTech | 30.70B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 26.40B |
| C&R Research | 24.08B |